Warning: The NCBI web site requires JavaScript to function. more...
Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective.
Auby P.
Child Adolesc Psychiatry Ment Health. 2008 Dec 8;2(1):38.
Related citations
The European Regulation on medicines for paediatric use.
Dunne J.
Paediatr Respir Rev. 2007 Jun;8(2):177-83. Epub 2007 May 30. Review.
Regulation (EC) No 1901/2006 on medicinal products for paediatric use & clinical research in vulnerable populations.
Lehmann B.
Child Adolesc Psychiatry Ment Health. 2008 Dec 8;2(1):37.
European perspectives on pediatric formulations.
Breitkreutz J.
Clin Ther. 2008 Nov;30(11):2146-54.
Paediatric medicines research in the UK: how to move forward?
Wong I, Sweis D, Cope J, Florence A.
Drug Saf. 2003;26(8):529-37. Review.
Clinical trials in paediatric oncology. Recommendations for the development of new anticancer agents.
Vassal G, Méry-Mignard D, Caulin C.
Therapie. 2003 May-Jun;58(3):229-46. English, French.
The European paediatric legislation: benefits and perspectives.
Rocchi F, Paolucci P, Ceci A, Rossi P.
Ital J Pediatr. 2010 Aug 17;36:56.
Children in clinical trials: survey on the current situation in paediatric university clinics in Germany.
Khan-Boluki J, Hundt F.
Ger Med Sci. 2008 Mar 10;6:Doc01.
Will children with cancer benefit from the new European Paediatric Medicines Regulation?
Vassal G.
Eur J Cancer. 2009 Jun;45(9):1535-46. Epub 2009 May 4.
Proposals for model-based paediatric medicinal development within the current European Union regulatory framework.
Manolis E, Pons G.
Br J Clin Pharmacol. 2009 Oct;68(4):493-501.
Developing paediatric medicines: identifying the needs and recognizing the challenges.
Ernest TB, Elder DP, Martini LG, Roberts M, Ford JL.
J Pharm Pharmacol. 2007 Aug;59(8):1043-55. Review.
Paediatric clinical pharmacology: at the beginning of a new era.
Hoppu K.
Eur J Clin Pharmacol. 2008 Feb;64(2):201-5. Epub 2007 Oct 31.
The status of paediatric medicines initiatives around the world-what has happened and what has not?
Hoppu K, Anabwani G, Garcia-Bournissen F, Gazarian M, Kearns GL, Nakamura H, Peterson RG, Sri Ranganathan S, de Wildt SN.
Eur J Clin Pharmacol. 2012 Jan;68(1):1-10. Epub 2011 Jul 6.
The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
Rocchi F, Tomasi P.
Pharmacol Res. 2011 Sep;64(3):169-75. Epub 2011 Mar 3. Review.
The EU paediatric regulation: effects on paediatric psychopharmacology in Europe.
Stoyanova-Beninska VV, Wohlfarth T, Isaac M, Kalverdijk LJ, van den Berg H, Gispen-de Wied C.
Eur Neuropsychopharmacol. 2011 Aug;21(8):565-70. Epub 2010 Jul 10. Review.
Draft EU regulation on paediatric medicines: some improvements but still far from perfect.
[No authors listed]
Prescrire Int. 2006 Feb;15(81):32-3.
Developing a European framework for research on children's medicines: an examination of the proposed EU regulation on medicinal products for paediatric use.
Seyberth HW, Demotes-Mainard J, Wrobel P.
Pediatr Nephrol. 2005 Nov;20(11):1537-40. Epub 2005 Sep 16. No abstract available.
Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK.
Dick A, Keady S, Mohamed F, Brayley S, Thomson M, Lloyd BW, Heuschkel R, Afzal NA.
Aliment Pharmacol Ther. 2003 Feb 15;17(4):571-5.
Challenges in pediatric drug development: a pharmaceutical industry perspective.
Rose K.
Paediatr Drugs. 2009;11(1):57-9.
Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE, Kleijnen J.
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on